Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osvaldo Rivera-Gonzalez

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 7, 2020
Endothelin-1 in the pathophysiology of obesity and insulin resistanceHaley N Jenkins, Osvaldo Rivera-Gonzalez, Yann Gibert, et al.
Pharmacological Reviews|April 7, 2023
<i>β</i>-Arrestins: Structure, Function, Physiology, and Pharmacological PerspectivesJürgen Wess, Antwi-Boasiako Oteng, Osvaldo Rivera-Gonzalez, et al.
Clinical Science (London, England : 1979)|July 19, 2021
Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese miceOsvaldo Rivera-Gonzalez, Natalie A Wilson, Laura E Coats, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 8, 2022
Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosusOsvaldo Rivera-Gonzalez, Clinton T Case, Natalie A Wilson, et al.
Acta Physiologica (Oxford, England)|August 3, 2024
Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese miceOsvaldo Rivera-Gonzalez, Megumi F Mills, Bridget D Konadu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|July 7, 2020
Endothelin-1 in the pathophysiology of obesity and insulin resistanceHaley N Jenkins, Osvaldo Rivera-Gonzalez, Yann Gibert, et al.
Pharmacological Reviews|April 7, 2023
<i>β</i>-Arrestins: Structure, Function, Physiology, and Pharmacological PerspectivesJürgen Wess, Antwi-Boasiako Oteng, Osvaldo Rivera-Gonzalez, et al.
Clinical Science (London, England : 1979)|July 19, 2021
Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese miceOsvaldo Rivera-Gonzalez, Natalie A Wilson, Laura E Coats, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 8, 2022
Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosusOsvaldo Rivera-Gonzalez, Clinton T Case, Natalie A Wilson, et al.
Acta Physiologica (Oxford, England)|August 3, 2024
Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese miceOsvaldo Rivera-Gonzalez, Megumi F Mills, Bridget D Konadu, et al.
Pageof 1